Association of Myocardial Enzyme Abnormality with Clinical Outcomes of Patients with COVID-19: A Retrospective Study
Table 2
Demographic and clinical characteristics of patients with/without myocardial injury on admission.
Total ()
With myocardial injury ()
Without myocardial injury ()
value
Age, median, (range), y
54 (36-66)
66 (56.5-78)
48 (35-64)
-3.502
<0.001
Sex (men)
44 (57.9%)
12 (66.7%)
32 (55.2%)
0.745
0.388
Fever
54 (71.1%)
9 (50.0%)
45 (77.6%)
5.083
0.024
Cough
42 (55.3%)
9 (50.0%)
33 (56.9%)
0.264
0.607
Chest pain/tightness
32 (42.1%)
7 (38.9%)
25 (43.1%)
0.1
0.752
Respiratory rate
21 (3.39)
22.3 (4.36)
20.7 (3.02)
0.09
Systolic pressure, mm Hg
128 (117-138)
124 (101-140)
130 (118.75-138)
-1.517
0.129
Diastolic pressure, mm Hg
80 (73-89)
75 (65.5-90)
80 (76-89)
-1.646
0.1
Hypertension
25 (32.9%)
6 (33.3%)
19 (32.8%)
0.002
0.964
Diabetes
11 (14.5%)
3 (16.7%)
8 (13.8%)
0.092
0.762
Cardiovascular and cerebrovascular diseases
15 (19.7%)
7 (38.9%)
8 (13.8%)
5.461
0.019
Chronic pulmonary disease
6 (7.9%)
4 (22.2%)
2 (3.4%)
6.658
0.01
With more than two comorbidities
15 (19.7%)
5 (27.8%)
10 (17.2%)
0.963
0.327
Severe
31 (40.8%)
13 (72.2%)
18 (31.0%)
9.649
0.002
Common
45 (73.2%)
5 (27.8%)
40 (69.0%)
Death
15 (19.7%)
11 (61.1%)
4 (6.9%)
25.487
<0.001
Discharge
59 (77.6%)
6 (33.3%)
53 (91.4%)
Continuous variables were presented as mean (standard deviation (SD)). Other continuous variables were presented as median (interquartile range (IQR)).
